Additionally, antimicrobial-like peptides such as (KLAKLAK)2 have been used to selectively disrupt mitochondrial membranes in tumor cells, and tumor-suppressor-derived peptides like p28, derived from p53, have shown potential in restoring defective apoptotic signaling pathways in p53-mutant cancers [138]. The gene discussed is TP53; the disease is neoplasm.